Zostavax (zoster vaccine live) / Merck (MSD) 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zostavax (zoster vaccine live) / Merck (MSD)
2014-000967-42: Strengthening memory immunity in the aged population by vaccinating pre-elderly Stimuleren van geheugen immuniteit in de ouder wordende populatie door mensen op middelbare leeftijd te vaccineren

Ongoing
4
250
Europe
Nimenrix, Zostavax, Nimenrix, Zostavax, Nimenrix, Zostavax, Nimenrix, Zostavax
National Institute for Public Health and the Environment (RIVM, Netherlands), National Institute for Public Health and the Environment (RIVM, The Netherlands)
The vaccine administered in this study is used to prevent meningococcal disease caused by the bacteria Neisseria meningitidis group A,C,W,Y (Nimenrix) and Herpes Zoster disease caused by the Varicella zoster virus (Zostavax). The vaccinaties toegediend in de studie worden gebruikt om meningokokkenziekte veroorzaakt door Neisseria meningitidis groep A,C,W,Y (Nimenrix) en Herpes Zoster veroorzaakt door het herpes zoster virus (Zostavax) te voorkomen.
 
 
NCT04169009: Persistence of Protection by Shingrix

Completed
4
105
US
Zostavax, Shingrix
University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID)
Herpes Zoster
03/23
06/24
VERVE, NCT01967316: Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users

Recruiting
2
125
US
Herpes Zoster Vaccine, Zostavax, Placebo, Normal Saline
University of Alabama at Birmingham, Oregon Health and Science University
Rheumatoid Arthritis
06/16
06/16
VERVE, NCT02538757: Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users

Active, not recruiting
2
125
US
Herpes Zoster Vaccine, Zostavax, Placebo, Normal Saline
University of Alabama at Birmingham, Oregon Health and Science University
Arthritis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, Ankylosing Spondylitis, Enteropathic Arthritis, Crohn's Disease, Inflammatory Arthritis
02/18
08/18
BMS-188667, NCT03604406: The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

Active, not recruiting
2
154
US
Varicella Zoster Vaccine, Zostavax, Placebo Injection, Shingrix
Kevin Winthrop, University of Alabama at Birmingham, Bristol-Myers Squibb
Herpes Zoster, Inflammatory Disease, Rheumatoid Arthritis
06/25
09/26
ACTRN12611000640909: Herpes Zoster Vaccine for Bone Marrow Transplant donors

Not yet recruiting
1/2
20
 
MERCK SHARP & DOHME, Investigator Driven Study- University of Sydney, MERCK SHARP & DOHME
Varicella zoster in immunsuppressed stem cell transplant recipients
 
 
VEGAS, NCT01953900: iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

Active, not recruiting
1
26
US
GD2 T cells, iC9-GD2-CAR-VZV-CTL, VZV vaccine, zostavax, Fludarabine, Fludara, Cyclophosphamide, Cytoxan
Baylor College of Medicine, National Cancer Institute (NCI), Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital Research Institute
Osteosarcoma, Neuroblastoma
10/19
10/34
NCT04089930: Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients

Completed
N/A
68
RoW
Immunogenicity
Tuen Mun Hospital, The University of Hong Kong
Lupus Erythematosus
09/23
10/23

Download Options